Inspire Medical Systems (INSP) Capital Expenditures (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Capital Expenditures data on file, last reported at $3.0 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 64.48% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $33.1 million (down 21.38% YoY), and the FY2025 full-year result was $38.5 million, down 1.59% from the prior year.
• Capital Expenditures slipped to $3.0 million in Q1 2026, from $10.7 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $28.2 million in Q3 2024 to a low of -$11.6 million in Q4 2023.
• A 5-year average of $5.5 million and a median of $3.8 million in 2023 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures tumbled 344.74% in 2022 and jumped 1092.17% in 2023, its largest moves.
• Tracing INSP's Capital Expenditures over 5 years: stood at $7.8 million in 2022, then plunged by 249.12% to -$11.6 million in 2023, then jumped by 160.69% to $7.0 million in 2024, then soared by 51.64% to $10.7 million in 2025, then slumped by 71.98% to $3.0 million in 2026.
• Business Quant data shows INSP's Capital Expenditures at $3.0 million in Q1 2026, $10.7 million in Q4 2025, and $22.1 million in Q3 2025.